Krystal Biotech, Inc. · NASDAQ:KRYS

Krishnan Krish S sold 25,000 Krystal Biotech, Inc. shares (Form 4)

Traded Sep 4, 2026 · Filed Sep 4, 2026

On Sep 4, 2026, Krishnan Krish S (Director, President and CEO, 10% owner) sold 25,000 Krystal Biotech, Inc. shares at an average US$359.32 for US$8.98M under a trading plan, leaving 1,347,543 shares. Filed Sep 4, 2026 (Form 4).

Sold
25,000 shares
Price
US$359.32 average (US$354.54 to US$366.56)
Value
US$8.98M
Holding after
1,347,543 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, President and CEO, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 4, 2026Common StockSale520US$354.541,372,023Direct
Sep 4, 2026Common StockSale2,029US$355.571,369,994Direct
Sep 4, 2026Common StockSale3,297US$356.371,366,697Direct
Sep 4, 2026Common StockSale3,981US$357.571,362,716Direct
Sep 4, 2026Common StockSale3,143US$358.421,359,573Direct
Sep 4, 2026Common StockSale3,357US$359.391,356,216Direct
Sep 4, 2026Common StockSale2,266US$360.461,353,950Direct
Sep 4, 2026Common StockSale1,214US$361.611,352,736Direct
Sep 4, 2026Common StockSale2,010US$362.651,350,726Direct
Sep 4, 2026Common StockSale573US$363.341,350,153Direct
Sep 4, 2026Common StockSale1,358US$364.481,348,795Direct
Sep 4, 2026Common StockSale847US$365.421,347,948Direct
Sep 4, 2026Common StockSale405US$366.561,347,543Direct

Source

View original at SEC

Related